In our study, while we did not observe a difference in clinical severity during the acute phase of ischemic stroke in relation to MCP-1 levels, we did observe differences in clinical deterioration during the progression of ischemic stroke in the first days of hospitalization. Here, CCL2 is linked to ischemic stroke.